Outcome of Monochorionic Monoamniotic Twin Reversed Arterial Perfusion Sequence Diagnosed in the First Trimester.


Journal

Fetal diagnosis and therapy
ISSN: 1421-9964
Titre abrégé: Fetal Diagn Ther
Pays: Switzerland
ID NLM: 9107463

Informations de publication

Date de publication:
2021
Historique:
received: 03 06 2021
accepted: 23 09 2021
pubmed: 15 12 2021
medline: 3 3 2022
entrez: 14 12 2021
Statut: ppublish

Résumé

The aim of this study is to evaluate the outcome of pregnancies complicated by monochorionic monoamniotic twin reversed arterial perfusion sequence (MOMA TRAP) diagnosed in the first trimester. All patients diagnosed with MOMA TRAP sequence <14.0 weeks of gestation in a 10-year study period were retrospectively analyzed for intrauterine course and outcome. All patients were offered either expectant management or intrauterine intervention. Adverse outcome was defined as either intrauterine death (IUD), neonatal death or preterm birth <34.0 weeks of gestation. In the study period, 17 cases with MOMA TRAP sequence were diagnosed. Of these, 2 couples opted for termination of pregnancy. The remaining 15 were divided into 2 groups depending on the management: group A (n = 8) with expectant management and group B (n = 7) with intrauterine intervention. All fetuses in group A died before 20 weeks. Survival in group B was significantly better with 4/7 (57.1%) life births at a median of 39.6 weeks of gestation (p = 0.0256). The reasons for IUD in the 3 cases in group B were hemodynamic, strangulation, and bleeding complications during intervention. Intrauterine intervention in MOMA TRAP pregnancies significantly improves neonatal survival, although it is still associated with a substantial risk for IUD by hemodynamic complications or entanglement.

Identifiants

pubmed: 34903686
pii: 000519860
doi: 10.1159/000519860
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

778-784

Informations de copyright

© 2021 S. Karger AG, Basel.

Auteurs

Eva Christin Weber (EC)

Department of Obstetrics and Prenatal Medicine, University Hospital Bonn, Bonn, Germany.

Florian Recker (F)

Department of Obstetrics and Prenatal Medicine, University Hospital Bonn, Bonn, Germany.

Ingo Gottschalk (I)

Division of Prenatal Medicine, University Hospital Cologne, Cologne, Germany.

Brigitte Strizek (B)

Department of Obstetrics and Prenatal Medicine, University Hospital Bonn, Bonn, Germany.

Annegret Geipel (A)

Department of Obstetrics and Prenatal Medicine, University Hospital Bonn, Bonn, Germany.

Ulrich Gembruch (U)

Department of Obstetrics and Prenatal Medicine, University Hospital Bonn, Bonn, Germany.

Christoph Berg (C)

Department of Obstetrics and Prenatal Medicine, University Hospital Bonn, Bonn, Germany.
Division of Prenatal Medicine, University Hospital Cologne, Cologne, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH